KESIMPTA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0078-1007 -
Package NDC
0078-1007-68 -
Package NDC
0078-1007-98 -
Application number
BLA125326 -
SPL ID
ab75831e-d802-456a-bae6-7c85ef8dc3ed -
SPL set ID
6a8a3f53-2062-48ff-9dbe-b939df133ca3 -
UNII
M95KG522R0 -
RxCUI
2390949 -
RxCUI
2390954
What the source publishes
- Labeler
- Novartis Pharmaceuticals Corporation
- Active ingredients
- ofatumumab
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "KESIMPTA",
"splId": "ab75831e-d802-456a-bae6-7c85ef8dc3ed",
"labels": [
{
"setId": "6a8a3f53-2062-48ff-9dbe-b939df133ca3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a8a3f53-2062-48ff-9dbe-b939df133ca3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6a8a3f53-2062-48ff-9dbe-b939df133ca3"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Novartis Pharmaceuticals Corporation",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS",
"package_ndc": "0078-1007-68",
"identifierStatus": "well-formed",
"marketing_start_date": "20200820"
},
{
"sample": true,
"description": "1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS",
"package_ndc": "0078-1007-98",
"identifierStatus": "well-formed",
"marketing_start_date": "20200820"
}
],
"productId": "0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "0078-1007",
"deaSchedule": null,
"genericName": "ofatumumab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OFATUMUMAB",
"strength": "20 mg/.4mL"
}
],
"applicationNumber": "BLA125326",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20091026",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175657",
"N0000175078"
],
"unii": [
"M95KG522R0"
],
"rxcui": [
"2390949",
"2390954"
],
"spl_set_id": [
"6a8a3f53-2062-48ff-9dbe-b939df133ca3"
],
"pharm_class_epc": [
"CD20-directed Cytolytic Antibody [EPC]"
],
"pharm_class_moa": [
"CD20-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Novartis Pharmaceuticals Corporation"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0078-1007_ab75831e-d802-456a-bae6-7c85ef8dc3ed"